Rui Avelar
Chief Tech/Sci/R&D Officer at EVOLUS, INC.
Net worth: 5 M $ as of 2024-03-30
Profile
Rui Avelar is currently the Chief Medical Officer, Head-Research & Development at Evolus, Inc. He previously held the position of Chief Medical Officer at Allergan Medical Optics from 2011 to 2013 and at AEON Biopharma Sub, Inc. from 2014 to 2018.
Dr. Avelar obtained his doctorate degree from the University of Toronto in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EVOLUS, INC.
0.61% | 2024-03-18 | 372,288 ( 0.61% ) | 5 M $ | 2024-03-30 |
Rui Avelar active positions
| Companies | Position | Start |
|---|---|---|
| EVOLUS, INC. | Chief Tech/Sci/R&D Officer | 2013-12-31 |
Former positions of Rui Avelar
| Companies | Position | End |
|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Chief Tech/Sci/R&D Officer | 2018-01-31 |
| Allergan Medical Optics | Chief Tech/Sci/R&D Officer | 2013-11-30 |
Training of Rui Avelar
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EVOLUS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Allergan Medical Optics | |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
- Stock Market
- Insiders
- Rui Avelar
